MUC1-C interacts with diverse effectors, such as β-catenin [9], IKK β [10], and NFkB p65 [11], which have been linked to transformation. Wnt and NFkB signaling pathways are known to be activated in colorectal cancer [12, 13]. Here, NFKB1 is linked to colorectal cancer.